Patients with BRCA mutations are offered breast MRI because of their increased risk of breast cancer, but no screening strategy is available for other BRCA-associated malignancies including pancreatic ductal adenocarcinoma. In this protocol, we optimize the use of several recent developments in body MRI for a rapid pancreatic screening in BRCA mutation carriers: first, rapid relatively motion insensitive T2-weighted imaging (T2WI) and navigator triggering (NT), where real-time tracking of the diaphragm position is performed. Secondly advances in diffusion-weighted-imaging (DWI). These techniques have changed our ability to screen for malignancies, in specific organs, such as the pancreas.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords